HUNTSVILLE, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced…
26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…
26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…
26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…
26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…
26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…
November 20, 2024 07:00 ET | Source: Voyager Therapeutics, Inc. - Candidate VY1706 demonstrates significant reductions of tau at low…
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort…